SOPHiA GENETICS SA (SOPH)
NASDAQ: SOPH · Real-Time Price · USD
5.00
+0.14 (2.88%)
At close: Apr 28, 2026, 4:00 PM EDT
5.00
0.00 (0.00%)
After-hours: Apr 28, 2026, 4:22 PM EDT

SOPHiA GENETICS Statistics

Total Valuation

SOPHiA GENETICS has a market cap or net worth of $360.49 million. The enterprise value is $353.22 million.

Market Cap 360.49M
Enterprise Value 353.22M

Important Dates

The next confirmed earnings date is Tuesday, May 5, 2026, before market open.

Earnings Date May 5, 2026
Ex-Dividend Date n/a

Share Statistics

SOPHiA GENETICS has 71.67 million shares outstanding. The number of shares has increased by 2.24% in one year.

Current Share Class 71.67M
Shares Outstanding 71.67M
Shares Change (YoY) +2.24%
Shares Change (QoQ) +1.05%
Owned by Insiders (%) 10.64%
Owned by Institutions (%) 30.23%
Float 51.54M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 4.67
Forward PS 3.79
PB Ratio 7.31
P/TBV Ratio 32.03
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 4.57
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 1.96, with a Debt / Equity ratio of 1.34.

Current Ratio 1.96
Quick Ratio 1.72
Debt / Equity 1.34
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -15.58

Financial Efficiency

Return on equity (ROE) is -110.00% and return on invested capital (ROIC) is -37.46%.

Return on Equity (ROE) -110.00%
Return on Assets (ROA) -27.85%
Return on Invested Capital (ROIC) -37.46%
Return on Capital Employed (ROCE) -63.05%
Weighted Average Cost of Capital (WACC) 9.36%
Revenue Per Employee $186,195
Profits Per Employee -$190,359
Employee Count 415
Asset Turnover 0.49
Inventory Turnover 4.12

Taxes

In the past 12 months, SOPHiA GENETICS has paid $1.51 million in taxes.

Income Tax 1.51M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +58.23% in the last 52 weeks. The beta is 1.04, so SOPHiA GENETICS's price volatility has been similar to the market average.

Beta (5Y) 1.04
52-Week Price Change +58.23%
50-Day Moving Average 4.79
200-Day Moving Average 4.37
Relative Strength Index (RSI) 53.78
Average Volume (20 Days) 94,382

Short Selling Information

The latest short interest is 175,963, so 0.25% of the outstanding shares have been sold short.

Short Interest 175,963
Short Previous Month 254,959
Short % of Shares Out 0.25%
Short % of Float 0.34%
Short Ratio (days to cover) 1.84

Income Statement

In the last 12 months, SOPHiA GENETICS had revenue of $77.27 million and -$79.00 million in losses. Loss per share was -$1.17.

Revenue 77.27M
Gross Profit 52.08M
Operating Income -70.93M
Pretax Income -77.49M
Net Income -79.00M
EBITDA -69.17M
EBIT -70.93M
Loss Per Share -$1.17
Full Income Statement

Balance Sheet

The company has $70.29 million in cash and $63.02 million in debt, giving a net cash position of $7.27 million or $0.10 per share.

Cash & Cash Equivalents 70.29M
Total Debt 63.02M
Net Cash 7.27M
Net Cash Per Share $0.10
Equity (Book Value) 47.15M
Book Value Per Share 0.69
Working Capital 48.55M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$35.89 million and capital expenditures -$574,000, giving a free cash flow of -$36.47 million.

Operating Cash Flow -35.89M
Capital Expenditures -574,000
Depreciation & Amortization 1.77M
Net Borrowing 32.69M
Free Cash Flow -36.47M
FCF Per Share -$0.51
Full Cash Flow Statement

Margins

Gross margin is 67.40%, with operating and profit margins of -91.80% and -102.24%.

Gross Margin 67.40%
Operating Margin -91.80%
Pretax Margin -100.28%
Profit Margin -102.24%
EBITDA Margin -89.51%
EBIT Margin -91.80%
FCF Margin n/a

Dividends & Yields

SOPHiA GENETICS does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -2.24%
Shareholder Yield -2.24%
Earnings Yield -21.91%
FCF Yield -10.12%

Analyst Forecast

The average price target for SOPHiA GENETICS is $7.50, which is 50.00% higher than the current price. The consensus rating is "Strong Buy".

Price Target $7.50
Price Target Difference 50.00%
Analyst Consensus Strong Buy
Analyst Count 2
Revenue Growth Forecast (5Y) 25.68%
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

SOPHiA GENETICS has an Altman Z-Score of -3.8 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -3.8
Piotroski F-Score 2